Stepan Company (SCL)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-11-04
$70.65+2.90%
Close 2026-11-04 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-11-04
QuarterlyIQ Insights · SCL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 2,534.7 | 2,332.1 | 2,180.3 | 2,325.8 | 2,773.3 | 2,346.0 | 1,869.8 | 1,858.7 | 1,993.9 | 1,925.0 | 1,766.2 | 1,776.2 | 1,927.2 | 1,880.8 | 1,803.7 | 1,843.1 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 1,925.0 | 1,766.2 | 1,776.2 | 1,927.2 | 1,880.8 | 1,803.7 | 1,843.1 |
| Cost of Revenues | 2,230.7 | 2,062.2 | 1,908.1 | 2,048.2 | 2,346.2 | 1,950.2 | 1,486.1 | 1,519.0 | 1,654.5 | 1,578.8 | 1,426.9 | 1,467.9 | 1,677.7 | 1,599.1 | 1,512.2 | 1,587.5 |
| Gross Profit | 303.9 | 269.9 | 272.2 | 277.6 | 427.1 | 395.8 | 383.6 | 339.7 | 339.3 | 346.2 | 339.3 | 308.2 | 249.6 | 281.7 | 291.6 | 255.6 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | — | 34.8 | 33.5 | 35.7 | 40.9 | 38.8 | 36.0 | 34.1 | 33.5 | 33.2 | 34.9 | 30.3 | 27.2 | 28.8 | 28.0 | — |
| Operating Income | 24.0 | 78.5 | 70.5 | 58.6 | 207.3 | 170.8 | 171.5 | 127.3 | 149.3 | 154.8 | 127.8 | 122.8 | 90.7 | 109.2 | 128.7 | 118.5 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | — | 11.4 | 10.4 | 9.6 | 9.1 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | 0.3 | 0.1 | 0.1 | — |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | 11.2 | 10.3 | 9.5 | — |
| Other Non-Operating Income / Expenses | (21.2) | (18.6) | (10.0) | (10.2) | (18.6) | 1.8 | (0.5) | (1.4) | (11.5) | (8.0) | (14.0) | (19.9) | (15.2) | (13.5) | (13.0) | (13.6) |
| Asset Writedown | — | — | — | — | — | — | — | — | — | — | — | 2.3 | 2.3 | — | — | — |
| EBT, Incl. Unusual Items | 2.8 | 59.9 | 60.4 | 48.4 | 188.7 | 172.5 | 171.1 | 125.9 | 137.8 | 146.9 | 113.8 | 102.9 | 75.5 | 95.6 | 115.7 | — |
| Income Tax Expense | (1.5) | 13.0 | 10.1 | 8.2 | 41.6 | 34.6 | 43.4 | 22.8 | 26.7 | 46.1 | 27.6 | 26.8 | 18.5 | 23.3 | 36.0 | 32.3 |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | — | — | — | 0.1 | 0.9 | (0.0) | (0.0) | (0.0) | 0.0 | 0.1 | (0.0) | (0.5) | 0.3 | 0.6 |
| Net Income | 4.3 | 46.9 | 50.4 | 40.2 | 147.2 | 137.8 | 126.8 | 103.1 | 111.1 | 100.8 | 86.2 | 76.0 | 57.1 | 72.8 | 79.4 | 72.0 |
| Per Share | ||||||||||||||||
| Basic EPS | 0.19 | 2.05 | 2.21 | 1.77 | 6.46 | 6.01 | 5.52 | 4.47 | 4.83 | 4.39 | 3.78 | 3.34 | 2.51 | 3.22 | 3.71 | 3.44 |
| Diluted EPS | 0.19 | 2.05 | 2.20 | 1.75 | 6.38 | 5.92 | 5.45 | 4.42 | 4.76 | 4.31 | 3.73 | 3.32 | 2.49 | 3.18 | 3.49 | 3.21 |
| Revenue per Share | 110.31 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.06 |
| Basic Weighted Avg Shares | 22.9 | 22.9 | 22.8 | 22.8 | 22.8 | 22.9 | 22.9 | 23.1 | 23.0 | 22.9 | 22.8 | 22.7 | 22.8 | 22.6 | 21.3 | 20.7 |
| Diluted Weighted Avg Shares | 23.0 | 22.9 | 22.9 | 22.9 | 23.1 | 23.3 | 23.3 | 23.3 | 23.3 | 23.4 | 23.1 | 22.9 | 22.9 | 22.9 | 22.7 | 22.4 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 204.6 | 182.7 | 164.0 | 302.0 | 261.7 | 253.4 | 206.0 | 230.4 | 233.9 | 202.8 | 189.8 | 154.5 | 165.6 | 180.0 | 165.6 |
| EBIT | 24.0 | 78.5 | 70.5 | 58.6 | 207.3 | 170.8 | 171.5 | 127.3 | 149.3 | 154.8 | 127.8 | 122.8 | 90.7 | 109.2 | 128.7 | 118.5 |
| Effective Tax Rate | -52.9% | — | — | 16.9% | 22.0% | 20.1% | 25.4% | 18.1% | 19.4% | 31.4% | 24.3% | 26.1% | 24.4% | 24.4% | 31.1% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.